Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
571.19B | 563.29B | 589.03B | 563.25B | 560.88B | Gross Profit |
75.71B | 69.54B | 78.43B | 75.99B | 73.61B | EBIT |
39.22B | 32.10B | 42.96B | 41.57B | 38.95B | EBITDA |
52.72B | 41.18B | 53.94B | 51.98B | 49.20B | Net Income Common Stockholders |
27.45B | 19.34B | 29.21B | 29.37B | 25.99B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
52.50B | 47.97B | 40.18B | 38.48B | 41.31B | Total Assets |
514.65B | 502.13B | 524.06B | 479.42B | 450.04B | Total Debt |
4.05B | 4.13B | 32.33B | 5.61B | 8.14B | Net Debt |
-48.45B | -37.24B | -2.78B | -27.65B | -27.85B | Total Liabilities |
146.59B | 155.41B | 180.57B | 148.61B | 139.35B | Stockholders Equity |
362.97B | 342.03B | 338.83B | 328.32B | 308.21B |
Cash Flow | Free Cash Flow | |||
25.55B | 53.10B | -5.58B | 13.32B | 26.31B | Operating Cash Flow |
44.27B | 61.78B | 5.24B | 25.47B | 37.50B | Investing Cash Flow |
-15.94B | -6.84B | -11.11B | -8.86B | -9.92B | Financing Cash Flow |
-17.21B | -48.23B | 6.17B | -20.26B | -19.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥351.82B | 12.16 | 2.82% | 1.04% | 3.13% | ||
76 Outperform | ¥128.40B | 11.04 | 3.63% | 5.77% | 62.13% | ||
76 Outperform | ¥63.04B | 11.94 | 4.97% | 14.94% | 13.18% | ||
69 Neutral | ¥336.66B | 17.03 | 3.62% | 5.92% | -6.78% | ||
68 Neutral | $372.97B | 13.03 | 8.05% | 3.24% | 2.73% | 17.82% | |
64 Neutral | $4.30B | 11.84 | 5.23% | 249.82% | 4.06% | -10.21% |